Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion.
about
Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in CancerGalectins in epithelial functionsInhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitorHigh-Throughput Approaches to the Development of Molecular Imaging Agents.Combinatorial peptide libraries: mining for cell-binding peptides.Phage display in molecular imaging and diagnosis of cancer.Galectin-3 regulates desmoglein-2 and intestinal epithelial intercellular adhesion.Phage display and molecular imaging: expanding fields of vision in living subjects.Activation of human T-helper/inducer cell, T-cytotoxic cell, B-cell, and natural killer (NK)-cells and induction of natural killer cell activity against K562 chronic myeloid leukemia cells with modified citrus pectin.The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancerLandscape phages and their fusion proteins targeted to breast cancer cells.Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide.Expression of antigen tf and galectin-3 in fibroadenoma.Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapySynthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles.Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine.Epithelial-to-Mesenchymal Transition of RPE Cells In Vitro Confers Increased β1,6-N-Glycosylation and Increased Susceptibility to Galectin-3 Binding.MUC1 is involved in trophoblast transendothelial migrationTumor-targeting peptides from combinatorial libraries.Kidney-targeted drug delivery systems.Galectin-3 mediates the effect of PDGF on pulmonary arterial hypertensionChemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis.Inhibition and detection of galectins.Galectin-3 in apoptosis, a novel therapeutic targetChemoprevention of Low-Molecular-Weight Citrus Pectin (LCP) in Gastrointestinal Cancer Cells.A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interactionThe inhibitory effects of a rhamnogalacturonan I (RG-I) domain from ginseng pectin on galectin-3 and its structure-activity relationship.Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model.The role of galectins in colorectal cancer progression.The sweet and bitter sides of galectins in melanoma progression.The sweet side of tumor immunotherapy.Potential directions for drug development against galectin-7 in cancer.Extracellular galectin-3 in tumor progression and metastasis.Galectin-3 inhibitors: a patent review (2008-present).A kidney-selective biopolymer for targeted drug delivery.Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma.Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer.PectaSol-C modified citrus pectin induces apoptosis and inhibition of proliferation in human and mouse androgen-dependent and- independent prostate cancer cells.Two birds, one stone: dual targeting of the cancer cell surface and subcellular mitochondria by the galectin-3-binding peptide G3-C12.Biotinylated N-Acetyllactosamine- and N,N-Diacetyllactosamine-Based Oligosaccharides as Novel Ligands for Human Galectin-3.
P2860
Q26744538-E35E3F41-1BC4-4494-93A5-946CDE4A5FB3Q27000800-F388E3D2-FE2D-4B01-977A-67F39A6E0699Q27675426-377E46C5-AB3D-4615-9D7D-950EC6203DCEQ30275493-17F4022A-C6EE-4978-983C-00BD34E73DC6Q31144876-6D172467-9C05-4574-8462-D3DA2D14F3C7Q33532734-26ADD6CF-B315-432B-AE38-BBFE5A8DB993Q33675740-444AE547-D256-4E73-8614-FB562E21EA7BQ33849788-0167A686-4119-42A4-85FD-8F5B29824A9AQ33982118-D1D3AF4A-5A5D-48B6-8A4C-E44F6C27D760Q34056427-10E5E73E-4718-4C9C-976D-CD23D077E871Q34227310-97CB3A2A-159A-4D9A-8C86-3F808962FFE4Q34360666-4118FB67-F2AD-42C7-908C-CEEAFDBBCD84Q34522377-389EA501-1E65-4DC6-A54E-AF2C2B40B063Q35127584-114BD811-96A7-4D94-8527-DECBB14D8FA9Q35162645-7E16D249-914D-4BFA-9C8F-72D2DDA2B6DBQ35763903-80BF6098-4E8F-46EC-B4D4-33B80CD37BAEQ35892475-9E21FA26-5575-4118-A081-DA1BE1B54734Q36002985-DEEC5955-16ED-4F95-8A42-8CB6BC1D1FD3Q36025723-30F76D37-FEB4-41F7-85F2-0A2260E126E3Q36111953-F32A506B-D853-4DA2-9C89-4B0F4B5A3B06Q36317485-A7CB5F1D-5F4C-4F96-A46C-7FD872977BA1Q36414261-3CDCBFBE-5D3E-4843-85F3-043006531C20Q36432498-A980BD76-D2AF-4FD2-BB34-7287D19FF0CCQ36743604-B1F10477-6C01-40F0-845E-D6BC7EFC0AD5Q36911100-53CDC3F6-132A-41BA-8B9F-DE94AD641CBAQ37328722-440F76FE-17B2-4159-8897-B88CC664B5BFQ37333778-65DCAE85-C364-4BB1-B70F-EDF1A18F1244Q37423079-B3D7F771-E682-4642-B563-E58FE23DA0E5Q37869015-1F2D15CD-FB09-42A5-BBF4-0D57DA4F60ACQ38016538-71FBDBE5-0C10-44F2-9CB1-B331CA0561DCQ38031282-4D9763A9-B924-434B-85AB-1AF9A3DE926DQ38089199-F3F3F86C-91DC-4467-A65C-ED3DA5A82EF0Q38225141-D6F75FBD-907B-4B0E-8091-46BC5F83ED9BQ38238525-CB585CE0-B17E-4767-8902-256BFDDEB4D7Q38804663-1FA34262-416A-42C8-84C1-1957B4D404A2Q38983451-DF19B09D-4266-4129-9C09-0E891B848331Q39445066-6F474AE6-EE8D-48DF-A94E-29C8AC31299FQ39704679-E3E813CA-F87B-4C9E-8383-AE9E19529FEFQ41078680-3CD15E1D-6081-4F52-B266-3BA1A8547C04Q41704323-818DCFAB-1703-4407-BC63-DF3E39C8829B
P2860
Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Peptides specific to the galec ...... sociated cancer cell adhesion.
@ast
Peptides specific to the galec ...... sociated cancer cell adhesion.
@en
type
label
Peptides specific to the galec ...... sociated cancer cell adhesion.
@ast
Peptides specific to the galec ...... sociated cancer cell adhesion.
@en
prefLabel
Peptides specific to the galec ...... sociated cancer cell adhesion.
@ast
Peptides specific to the galec ...... sociated cancer cell adhesion.
@en
P2093
P356
P1433
P1476
Peptides specific to the galec ...... ssociated cancer cell adhesion
@en
P2093
Leslie Matthews
Linda A Landon
Susan L Deutscher
P304
P356
10.1093/CARCIN/BGH329
P407
P577
2004-11-04T00:00:00Z